Citation

82 FR 56622

Multiple canonical documents share this first-page citation.

National Cancer Institute; Notice of Closed Meetings Wednesday, November 29, 2017 82 FR 56622
Prospective Grant of Exclusive Patent License: T-Cells Transduced with HLA A11 Restricted CT-RCC HERV-E Reactive T-Cell Receptors for the Treatment of Renal Cell Carcinoma Wednesday, November 29, 2017 82 FR 56622